Tender Details

Country: Canada
Summary: Molecular Assay for Drug Resistant Tb Testing
CAT Ref No: 101345046
Deadline: 21 May 2024
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: tender_18543
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
PHO believes that the following procurement qualifies as a sole source or single source procurement. The purpose of this Advanced Contract Award Notice (ACAN) is to determine if there are other proponents capable of meeting the requirements of the procurement for the following supplies for PHO.

Vendor: Becton Dickinson Canada Inc
Product: BD Max MDR-TB Assay
Purpose: A Health Canada approved assay for the detection of drug resistant Mycobacterium tuberculosis. The drug resistance targets sought as part of this assay are for isoniazid and rifampin.

PHO has a requirement a commercial Health Canada approved molecular assay for detection of drug resistant Mycobacterium tuberculosis, with drug resistance targets of isoniazid and rifampin. Recent changes to the Canadian Tuberculosis Standards require a test with a short turnaround time to determine prompt treatment for individuals with M. tuberculosis detected by molecular assays. As such, PHO requires supply of an assay which is capable of detecting multidrug resistant tuberculosis from clinical specimens, as well as culture isolates.
PHO believes that the BD MAX MDR-TB Assay is the only commercial Health Canada approved assay for this use capable of detecting isoniazid and rifampin resistant M. tuberculosis.

PHO intends to award a 5 year term contract (comprised of 2 firm years and 3 one-year options) to Becton Dickinson for the products described above.

This request does not constitute a call...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Molecular Assay for Drug Resistant Tb Testing - Canada Tender

The PUBLIC HEALTH ONTARIO, a Government sector organization in Canada, has announced a new tender for Molecular Assay for Drug Resistant Tb Testing. This tender is published on CanadaTenders under CAT Ref No: 101345046 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-05-21.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.